Secondary leukaemia & myelodysplasia, hepatosplenic T-cell lymphoma in patients w/ IBD when used in combination w/ anti-TNF agents, bone marrow suppression, leucopenia, thrombocytopenia, nausea, vomiting, pancreatitis in IBD population, biliary stasis, hepatotoxicity, arthralgia, skin rash, drug fever, facial oedema. Hepatic necrosis, alopecia, transient oligospermia.